A Study of Ponatinib With Chemotherapy in Children, Teenagers, and Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Clinical trial NCT04501614 · TERMINATED

Trial details

NCT number: NCT04501614
Sponsor: Takeda
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pediatric Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ALL)Ph+ Mixed Phenotype Acute Leukemia (MPAL)Philadelphia Chromosome-Like ALL (Ph-like ALL)

Start date: 2021-02-24
Primary completion: 2023-12-19
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.